Document detail
ID

oai:pubmedcentral.nih.gov:1139...

Topic
Articles
Author
Genis, Cankat Sengul Emeksiz, Zeynep Buyuk Yaytokgil, Sule Ginis, Tayfur Islamoglu, Candan Dibek Misirlioglu, Emine
Langue
en
Editor

OceanSide Publications, Inc.

Category

Allergy and Asthma Proceedings

Year

2024

listing date

9/18/2024

Keywords
amphotericin anaphylaxis applied protocols five protocol treatment pediatric patients desensitization
Metrics

Abstract

BACKGROUND: Liposomal amphotericin B (LAMB) is a crucial agent in the treatment of invasive fungal diseases caused by a wide variety of yeasts and molds.

In the presence of an infection caused by a fungal agent resistant to alternative antifungal drugs, desensitization may be the only option to continue treatment.

However, there is insufficient information and consensus with regard to amphotericin B desensitization protocols in the pediatric age group.

OBJECTIVE: We present our experience with five cases of patients in whom successful desensitization protocols were applied with LAMB, along with a review of the literature on pediatric cases.

We also provide a sample desensitization protocol that we successfully applied.

METHODS: Pediatric patients who continued their treatment with the successful rapid desensitization protocol conducted at the Paediatric Allergy and Immunology Clinic of the Ministry of Health Ankara City Hospital between September 2019 and September 2023 were examined.

Desensitization protocols were applied based on Castells’ desensitization protocol.

RESULTS: Five patients ages between 5 and 12 years were referred to us due to the development of anaphylaxis during their treatment with LAMB.

Anaphylaxis is diagnosed clinically, according to the European Academy of Allergy and Clinical Immunology guidelines: anaphylaxis (2021 update).

A 16-step desensitization protocol was prepared by using LAMB solutions at four different dilutions (0.001, 0.01, 0.1, and 1 mg/mL).

Each solution consisted of four steps, with a 15-minute infusion for each step.

The patients were premedicated with 1 mg/kg/dose methylprednisolone and an antihistamine.

CONCLUSION: The data we present on the successful application of a sample protocol to five cases, particularly in a pediatric setting, are noteworthy valuable contributions to the field, which demonstrates the feasibility and success of rapid desensitization with LAMB in pediatric patients.

This can provide important insights and potentially serve as a reference for medical professionals working with similar cases in the future.

Genis, Cankat,Sengul Emeksiz, Zeynep,Buyuk Yaytokgil, Sule,Ginis, Tayfur,Islamoglu, Candan,Dibek Misirlioglu, Emine, 2024, Successful rapid liposomal amphotericin B desensitization in pediatric case series, OceanSide Publications, Inc.

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI